New combo pill for heart failure put to the test in healthy volunteers
NCT ID NCT07015671
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a new tablet combining two heart failure medicines (torsemide and spironolactone) works in the body compared to taking each drug separately. Twenty-four healthy adults aged 18 to 45 took single doses of the combination or the individual drugs. The goal was to see if the combination tablet releases the drugs properly and is absorbed similarly to the separate pills.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALENCE STUDY IN HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sarfez Pharmaceuticals
Vienna, Virginia, 22182, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Will a new drug form work the same? study tests two versions of SKI-O-703
- Diabetes drug copycat put to the test in healthy volunteers
- Generic diabetes combo pill put to the test in healthy volunteers
- Diabetes drug showdown: are two pills equally effective?
- Generic diabetes combo drug put to the test in healthy volunteers
- Generic Alzheimer's patch put to the test in healthy volunteers